Digestive Disease Research Center, Scott & White, Texas A&M Health Science Center, 702 SW H.K. Dodgen Loop, Temple, TX 76504, USA.
Dig Liver Dis. 2010 Apr;42(4):245-52. doi: 10.1016/j.dld.2010.01.008. Epub 2010 Feb 13.
Bile duct epithelial cells (i.e., cholangiocytes), which line the intrahepatic biliary epithelium, are the target cells in a number of human cholestatic liver diseases (termed cholangiopathies). Cholangiocyte proliferation and death is present in virtually all human cholangiopathies. A number of recent studies have provided insights into the key mechanisms that regulate the proliferation and function of cholangiocytes during the pathogenesis of cholestatic liver diseases. In our review, we have summarised the most important of these recent studies over the past 3 years with a focus on those performed in the animal model of extrahepatic bile duct ligation. In the first part of the review, we provide relevant background on the biliary ductal system. We then proceed with a general discussion of the factors regulating biliary proliferation performed in the cholestatic animal model of bile duct ligation. Further characterisation of the factors that regulate cholangiocyte proliferation and function will help in elucidating the mechanisms regulating the pathogenesis of biliary tract diseases in humans and in devising new treatment approaches for these devastating diseases.
胆管上皮细胞(即胆管细胞)排列在肝内胆管上皮内,是许多人类胆汁淤积性肝病(称为胆管疾病)的靶细胞。实际上,所有人类胆管疾病都存在胆管细胞增殖和死亡。最近的一些研究提供了对调节胆汁淤积性肝病发病过程中胆管细胞增殖和功能的关键机制的深入了解。在我们的综述中,我们总结了过去 3 年中这些最近研究中最重要的部分,重点是在肝外胆管结扎的动物模型中进行的研究。在综述的第一部分,我们提供了有关胆管系统的相关背景。然后,我们将对在胆汁淤积性动物模型中调节胆管增殖的因素进行一般性讨论。进一步阐明调节胆管细胞增殖和功能的因素将有助于阐明调节人类胆道疾病发病机制的机制,并为这些破坏性疾病设计新的治疗方法。